Literature DB >> 19120909

Correlations among total colonoscopic findings, clinical symptoms, and laboratory markers in ulcerative colitis.

Taro Osada1, Toshifumi Ohkusa, Isao Okayasu, Tsutomu Yoshida, Shu Hirai, Kazuko Beppu, Tomoyoshi Shibuya, Naoto Sakamoto, Osamu Kobayashi, Akihito Nagahara, Takeshi Terai, Sumio Watanabe.   

Abstract

BACKGROUND AND AIM: Colonoscopy plays an integral role in the diagnosis, management and surveillance of ulcerative colitis (UC). In the present study we assessed the relationship between endoscopic and histological findings, clinical symptoms, and laboratory data.
METHODS: We performed total colonoscopy examinations in 54 consecutive patients with UC. Seven segments (appendiceal region, cecum, ascending colon, transverse colon, descending colon, sigmoid colon, and rectum) were scored for endoscopic and histological activity. The patients were also evaluated using a symptom-activity index and laboratory markers: C-reactive protein (CRP), erythrocyte sedimentation rate (ESR), and white blood cell (WBC) and platelet (plt) counts.
RESULTS: There was a significant positive correlation between endoscopic and histological scores (r(s)=0.738), and between symptom activity score, endoscopic score (r(s)=0.444), and histological score (r(s)=0.557). Although the endoscopic and histological scores of distal colonic lesions (rectum-sigmoid, endoscopic: r(s)=0.515, histological: r(s)=0.624) correlated with clinical symptoms, there was no similar correlation for the proximal colon (appendiceal region-descending; endoscopic, r(s)=0.268, histological, r(s)=0.329). CRP, ESR, and WBC count also correlated with the sum of endoscopic and histological scores (CRP, r(s)=0.447, r(s)=0.369; ESR, r(s)=0.483, r(s)=0.589; WBC, r(s)=0.338, r(s)=0.330), whereas platelet count did not (r(s)=0.171, r(s)=0.210). In particular, CRP and ESR were well correlated with the activity of proximal colonic lesions (CRP, r(s) = 0.474, r(s)=0.480; ESR, r(s) = 0.423, r(s)=0.529) rather than with that of distal lesions (CRP, r(s)=0.236, r(s)=0.212; ESR, r(s)=0.368, r(s)=0.497).
CONCLUSIONS: In this study, clinical symptoms reflected the activity of distal colonic lesions, whereas CRP and ESR reflected the activity of proximal lesions. Therefore, total colonoscopy may be indicated when CRP or ESR is elevated in UC patients in clinical remission.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 19120909     DOI: 10.1111/j.1440-1746.2008.05413.x

Source DB:  PubMed          Journal:  J Gastroenterol Hepatol        ISSN: 0815-9319            Impact factor:   4.029


  22 in total

Review 1.  Noninvasive methods in evaluation of inflammatory bowel disease: where do we stand now? An update.

Authors:  Cansel Turkay; Benan Kasapoglu
Journal:  Clinics (Sao Paulo)       Date:  2010-02       Impact factor: 2.365

2.  How useful are blood and stool biomarkers for detecting subclinical mucosal inflammation in ulcerative colitis?

Authors:  Byong Duk Ye
Journal:  Dig Dis Sci       Date:  2014-01-17       Impact factor: 3.199

Review 3.  Current best practice for disease activity assessment in IBD.

Authors:  Alissa J Walsh; Robert V Bryant; Simon P L Travis
Journal:  Nat Rev Gastroenterol Hepatol       Date:  2016-09-01       Impact factor: 46.802

4.  Correlations of C-reactive protein levels and erythrocyte sedimentation rates with endoscopic activity indices in patients with ulcerative colitis.

Authors:  Jin Young Yoon; Soo Jung Park; Sung Pil Hong; Tae Il Kim; Won Ho Kim; Jae Hee Cheon
Journal:  Dig Dis Sci       Date:  2013-12-19       Impact factor: 3.199

5.  Correlation of C-reactive protein with clinical and endoscopic activity in patients with ulcerative colitis.

Authors:  Sami Karoui; Sonia Laz; Meriem Serghini; Norsaf Bibani; Jalel Boubaker; Azza Filali
Journal:  Dig Dis Sci       Date:  2010-12-03       Impact factor: 3.199

6.  Correlation of Hypoxia-inducible facto-1α and C-reactive protein with disease evaluation in patients with ulcerative colitis.

Authors:  Shuxia Yu; Bin Li; Jinghua Hao; Xiuju Shi; Jian Ge; Hongwei Xu
Journal:  Am J Transl Res       Date:  2020-12-15       Impact factor: 4.060

7.  Comparison between quantitative assessment of bowel wall vascularization by contrast-enhanced ultrasound and results of histopathological scoring in ulcerative colitis.

Authors:  Christiane Girlich; Doris Schacherer; Ernst Michael Jung; Frank Klebl; Elisabeth Huber
Journal:  Int J Colorectal Dis       Date:  2011-08-17       Impact factor: 2.571

8.  Energy expenditure in Japanese patients with severe or moderate ulcerative colitis.

Authors:  Masaya Sasaki; Tomoko Johtatsu; Mika Kurihara; Hiromi Iwakawa; Toshihiro Tanaka; Shigeki Bamba; Tomoyuki Tsujikawa; Yoshihide Fujiyama; Akira Andoh
Journal:  J Clin Biochem Nutr       Date:  2010-04-23       Impact factor: 3.114

9.  Histologic markers of inflammation in patients with ulcerative colitis in clinical remission.

Authors:  Laura Rosenberg; Kavinderjit S Nanda; Talia Zenlea; Anne Gifford; Garrett O Lawlor; Kenneth R Falchuk; Jacqueline L Wolf; Adam S Cheifetz; Jeffrey D Goldsmith; Alan C Moss
Journal:  Clin Gastroenterol Hepatol       Date:  2013-04-13       Impact factor: 11.382

Review 10.  Selecting Therapeutic Targets in Inflammatory Bowel Disease (STRIDE): Determining Therapeutic Goals for Treat-to-Target.

Authors:  L Peyrin-Biroulet; W Sandborn; B E Sands; W Reinisch; W Bemelman; R V Bryant; G D'Haens; I Dotan; M Dubinsky; B Feagan; G Fiorino; R Gearry; S Krishnareddy; P L Lakatos; E V Loftus; P Marteau; P Munkholm; T B Murdoch; I Ordás; R Panaccione; R H Riddell; J Ruel; D T Rubin; M Samaan; C A Siegel; M S Silverberg; J Stoker; S Schreiber; S Travis; G Van Assche; S Danese; J Panes; G Bouguen; S O'Donnell; B Pariente; S Winer; S Hanauer; J-F Colombel
Journal:  Am J Gastroenterol       Date:  2015-08-25       Impact factor: 10.864

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.